News

Manufacturing and logistics are under increasing pressure to become more efficient, more flexible, and more resilient. As ...
CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...